XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 7 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net loss $ (5,856) $ (349,248)
Adjustments to reconcile net loss to net cash used in operating activities:    
Formation cost paid through advances from affiliate of Sponsor 5,000
Interest earned on investments held in Trust Account (28,006)
Change in fair value of warrant liability (2,872,800)
Initial classification of ordinary shares subject to possible redemption 2,599,200
Transaction costs allocated to private warrants 30,212
Changes in operating assets and liabilities:    
Prepaid expenses (116,536)
Accounts payable and accrued expenses 43,569
Net cash used in operating activities (856) (693,609)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (139,380,000)
Net cash used in investing activities (139,380,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 135,600,000
Proceeds from sale of Private Placement Warrants 5,130,000
Advances from related party 25,000 25,000
Repayment of advances from related party (55,000)
Proceeds from promissory note – related party 125,000
Repayment of promissory note – related party (125,000)
Payment of offering costs (70,279) (416,260)
Net cash provided by financing activities 79,721 140,158,740
Net Change in Cash 78,865 85,131
Cash – Beginning of period 30,511
Cash – End of period 78,865 115,642
Non-Cash investing and financing activities:    
Deferred underwriting fee payable 5,190,000
Offering costs included in accrued offering costs $ 13,745